论文部分内容阅读
目的:探讨中医药分阶段结合化疗治疗晚期非小细胞肺癌的临床效果。方法:将56例晚期非小细胞肺癌患者分为对照组和观察组各28例,对照组采用单纯化疗,观察组在对照组基础上结合中医药分阶段结合治疗。化疗结束后,比较两组患者的临床症状、毒副反应、生存周期等。结果:观察组咳嗽、气促、胸痛等症状改善情况优于对照组,差异有统计学意义(P<0.05);观察组毒副反应发生率低于对照组,差异有统计学意义(P<0.05);观察组中位生存期长于对照组,差异有统计学意义(P<0.05)。结论:中医药分阶段结合化疗治疗晚期非小细胞肺癌能提高疗效,改善生存质量,有积极的临床意义。
Objective: To explore the clinical effects of Chinese medicine in combination with chemotherapy in the treatment of advanced non-small cell lung cancer. METHODS: Fifty-six patients with advanced non-small-cell lung cancer were divided into control group and 28 cases in the observation group. The control group was treated with chemotherapy alone. The observation group was combined with Chinese medicine in combination with stage treatment on the basis of the control group. After the end of chemotherapy, the clinical symptoms, toxicities and life cycle of the two groups were compared. Results: The symptoms of cough, shortness of breath and chest pain in the observation group were better than those in the control group (P<0.05). The incidence of adverse reactions in the observation group was lower than that in the control group, and the difference was statistically significant (P< 0.05); The median survival time of the observation group was longer than that of the control group, and the difference was statistically significant (P<0.05). Conclusion: Phased chemotherapy combined with chemotherapy for advanced non-small cell lung cancer can improve the efficacy and improve the quality of life, which has positive clinical significance.